[go: up one dir, main page]

MX2009003129A - Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras. - Google Patents

Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.

Info

Publication number
MX2009003129A
MX2009003129A MX2009003129A MX2009003129A MX2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A
Authority
MX
Mexico
Prior art keywords
inflammatory
oxadiazole derivatives
immunosuppressive properties
immunosuppressive
properties
Prior art date
Application number
MX2009003129A
Other languages
English (en)
Inventor
Sven Weiler
Frederic Zecri
Rainer Albert
Nigel Graham Cooke
Ian Lewis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009003129A publication Critical patent/MX2009003129A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se dan a conocer compuestos policíclicos de la siguiente fórmula I: (ver fórmula (I)) y su uso como agentes anti-inflamatorios e inmunosupresores.
MX2009003129A 2006-09-29 2007-09-27 Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras. MX2009003129A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121495 2006-09-29
PCT/EP2007/008431 WO2008037476A1 (en) 2006-09-29 2007-09-27 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties

Publications (1)

Publication Number Publication Date
MX2009003129A true MX2009003129A (es) 2009-04-06

Family

ID=37771076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003129A MX2009003129A (es) 2006-09-29 2007-09-27 Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.

Country Status (11)

Country Link
US (1) US20100087491A1 (es)
EP (1) EP2081916A1 (es)
JP (1) JP2010504932A (es)
KR (1) KR20090057070A (es)
CN (1) CN101522646A (es)
AU (1) AU2007302262A1 (es)
BR (1) BRPI0717656A2 (es)
CA (1) CA2664268A1 (es)
MX (1) MX2009003129A (es)
RU (1) RU2009115963A (es)
WO (1) WO2008037476A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149853A (en) 2006-09-07 2013-10-31 Actelion Pharmaceuticals Ltd Pyridin-4-yl derivatives as immunomodulating agents
AR062684A1 (es) 2006-09-08 2008-11-26 Actelion Pharmaceuticals Ltd Compuestos derivados de piridin-3- ilo, composicion farmaceutica que los contiene, y uso de los mismos en la preparacion de medicamentos
JP5250556B2 (ja) 2006-09-21 2013-07-31 アクテリオン ファーマシューティカルズ リミテッド フェニル誘導体及びそれらの免疫調節薬としての使用
AU2007334436A1 (en) 2006-12-15 2008-06-26 Abbott Laboratories Novel oxadiazole compounds
DK2125797T3 (da) 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
MX2010003614A (es) 2007-10-04 2010-04-21 Merck Serono Sa Compuestos de diarilo oxadiazol.
EP2193125B1 (en) 2007-10-04 2017-01-11 Merck Serono S.A. Oxadiazole derivatives
JP5435745B2 (ja) * 2008-03-07 2014-03-05 アクテリオン ファーマシューティカルズ リミテッド 免疫調節剤としてのピリジン−２−イル誘導体
KR20100125380A (ko) 2008-03-07 2010-11-30 액테리온 파마슈티칼 리미티드 신규한 아미노메틸 벤젠 유도체
PL2291080T3 (pl) 2008-05-14 2015-12-31 Scripps Research Inst Nowe modulatory receptorów sfingozyno-1-fosforanu
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives
KR101409131B1 (ko) 2009-07-16 2014-06-17 액테리온 파마슈티칼 리미티드 피리딘-4-일 유도체
US8399451B2 (en) 2009-08-07 2013-03-19 Bristol-Myers Squibb Company Heterocyclic compounds
EP2496231A1 (en) * 2009-11-05 2012-09-12 Lexicon Pharmaceuticals, Inc. Tryptophan hydroxylase inhibitors for the treatment of cancer
WO2011133734A1 (en) 2010-04-23 2011-10-27 Bristol-Myers Squibb Company 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
US8318783B2 (en) 2010-04-27 2012-11-27 Allergan, Inc. 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
TW201206429A (en) * 2010-07-08 2012-02-16 Merck Serono Sa Substituted oxadiazole derivatives
CN103237795B (zh) 2010-09-24 2015-10-21 百时美施贵宝公司 经取代的噁二唑化合物及其作为s1p1激动剂的用途
KR101317492B1 (ko) * 2010-09-29 2013-10-15 가톨릭대학교 산학협력단 Ａｇ490을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
WO2012098505A1 (en) 2011-01-19 2012-07-26 Actelion Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
EP3298008B1 (en) 2015-05-20 2019-11-20 Idorsia Pharmaceuticals Ltd Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
JP7086945B2 (ja) 2016-09-29 2022-06-20 レセプトス・リミテッド・ライアビリティ・カンパニー 狼瘡を処置するための化合物および方法
US10676467B2 (en) * 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof
CN107827837B (zh) * 2017-11-21 2021-09-24 苏州朗科生物技术股份有限公司 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用
KR102830313B1 (ko) * 2021-01-08 2025-07-09 광주과학기술원 신규한 트립토판 수산화효소 저해제 및 이의 용도
CN115974807B (zh) * 2023-01-18 2024-05-31 中国药科大学 2-苯基-5-联苯基-1,3,4-噁二唑类化合物及其制备方法、药物组合物和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings
JP4219810B2 (ja) * 2001-10-26 2009-02-04 塩野義製薬株式会社 Ｍｍｐ阻害作用を有するスルホンアミド誘導体
JP2005533058A (ja) * 2002-06-17 2005-11-04 メルク　エンド　カムパニー　インコーポレーテッド Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
EP1670463A2 (en) * 2003-10-01 2006-06-21 Merck & Co., Inc. 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
WO2006001463A1 (ja) * 2004-06-23 2006-01-05 Ono Pharmaceutical Co., Ltd. Ｓ１ｐ受容体結合能を有する化合物およびその用途
CN101043887A (zh) * 2004-10-22 2007-09-26 默克公司 用作s1p受体激动剂的2－(芳基)氮杂环甲基羧酸酯、磺酸酯、膦酸酯、次膦酸酯和杂环化合物
EP2371811B1 (en) * 2004-12-13 2014-10-08 Ono Pharmaceutical Co., Ltd. Azetidinecarboxylic acid derivative and medicinal use thereof
BRPI0612028A2 (pt) * 2005-06-08 2010-10-13 Novartis Ag oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p
EP1932833B1 (en) * 2005-10-07 2012-08-01 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物

Also Published As

Publication number Publication date
JP2010504932A (ja) 2010-02-18
RU2009115963A (ru) 2010-11-10
US20100087491A1 (en) 2010-04-08
CA2664268A1 (en) 2008-04-03
BRPI0717656A2 (pt) 2014-04-29
CN101522646A (zh) 2009-09-02
EP2081916A1 (en) 2009-07-29
WO2008037476A1 (en) 2008-04-03
KR20090057070A (ko) 2009-06-03
AU2007302262A1 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
MX2009003129A (es) Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
MX2009008798A (es) Derivados de iminipiridina y sus usos como microbicidas.
MX2012008049A (es) Compuestos heterociclicos triciclicos, composiciones y metodos de uso de los mismos,.
MY154909A (en) Novel thiophene derivatives
IL192948A0 (en) Novel pyridine derivatives
ECSP10010722A (es) Compuestos orgánicos
MX2009007077A (es) Analogos de ciclopamina.
MY153921A (en) Aminopyrazole derivatives
MX2007004699A (es) Derivados de indol y bencimidazol.
TW200612958A (en) Substituted imidazole derivatives
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CL2012000707A1 (es) Compuestos derivados de [5-(pirrolo[1,2-c][1.2.3]triazin-7-il)tetrahidrofuran-2-il]metanol; composición farmacéutica; y su uso para el tratamiento de la hepatitis c.
PH12012501905A1 (en) Quinoline derivatives and their use as fungicides
WO2007115821A3 (en) Organic compounds
MX2010004576A (es) Derivados de pirimidina novedosos.
TW200716591A (en) Novel thiophene derivatives
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
TW200833324A (en) Sulfonamide derivatives
TW200716552A (en) Novel thiophene derivatives
TN2009000287A1 (en) Cyclized derivatives as eg-5inhibitors
TW200738670A (en) Novel thiophene derivatives
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
TN2009000178A1 (en) Substituted pyrazole and triazole compounds as ksp inhibitors
WO2010027424A3 (en) 9-substituted phenanthrene based tylophorine derivatives
SG158091A1 (en) Imidazoazepinone compounds

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal